HBV Citations List: February 2025

Literature Citations

1. Discovery of Bimodal Hepatitis B Virus Ribonuclease H and Capsid Assembly Inhibitors. Bradley, D.P., C.J. Valkner, Q. Li, M. Gasonoo, M.J. Meyers, G.M. Prifti, D. Moianos, G. Zoidis, A. Zlotnick and J.E. Tavis. PLoS Pathogens, 2025. 21(2): e1012920. PMID[39928681]. PMCID[PMC11828405].
[PubMed]. HBV_02_2025.

2. Glycoconjugates of Adefovir and Tenofovir as Asialoglycoprotein-mediated Anti-HBV Prodrugs with Enhanced Liver Targeting. Chen, L., M. Deng, W. Yan, Z. Zeng, D. Chen, Y. Zhao, Y. Wu, Y. Li and B. He. European Journal Medicinal Chemistry, 2025. 284: 117207. PMID[39746236].
[PubMed]. HBV_02_2025.

3. Endothelial Lipase-binding Peptides Similar to Netrin-1 Inhibit Hepatitis B Virus Infection. Ide, M., N. Tabata, K. Murai, Y. Yonemura, Y. Wang, A. Ishida, T. Shirasaki, S. Kaneko, S. Ito, M. Honda and H. Yanagawa. FEBS Letters, 2025. ISI[001405026700001].
[WOS]. HBV_02_2025.

Patent Citations

This month, no relevant HBV patents were identified.